Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Weill Medical College of Cornell University
State University of New York at Buffalo
National Institutes of Health Clinical Center (CC)
Institut Paoli-Calmettes
Varian, a Siemens Healthineers Company
PROCEPT BioRobotics
Case Comprehensive Cancer Center
University College, London
Mayo Clinic
Peking University First Hospital
Centers for Disease Control and Prevention
Masaryk Memorial Cancer Institute
University of Virginia
M.D. Anderson Cancer Center
University of California, San Francisco
Boston Scientific Corporation
Beni-Suef University
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Boston Scientific Corporation
M.D. Anderson Cancer Center
Axonics, Inc.
University Hospital Tuebingen
Ankara City Hospital Bilkent
University of Alabama at Birmingham
Thomas Jefferson University
NCBJ Polatom: Narodowe Centrum Badań Jądrowych Polatom
University Hospital, Bordeaux
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
Canadian Cancer Trials Group
Stanford University
Institute for Clinical and Experimental Medicine
The New York Proton Center
University of Alberta
Francis Medical Inc.
First Affiliated Hospital of Fujian Medical University
First Affiliated Hospital of Fujian Medical University
Virtuoso Surgical, Inc.
National Cancer Institute (NCI)
University of Utah
Umeå University
University of Michigan Rogel Cancer Center
Benha University
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University Hospital, Bordeaux